Dr. Carter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1982 - 1985
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1981 - 1982
- Mayo Clinic College of MedicineClass of 1981
Certifications & Licensure
- NH State Medical License 2015 - Present
- AZ State Medical License 1986 - 2026
- NV State Medical License 2015 - 2017
- VT State Medical License 2014 - 2016
- MN State Medical License 1987 - 1998
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 13 citationsCerebral enhancement in MOG antibody-associated disease.Paul Elsbernd, Laura Cacciaguerra, Karl N Krecke, John J Chen, David Gritsch
Journal of Neurology, Neurosurgery, and Psychiatry. 2023-12-14 - 1 citationsRetinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: Critical Role of Retina Specialists.Odette M Houghton, Jonathan Carter, Radhika Dhamija
Journal of Vitreoretinal Diseases. 2022-12-03 - 4 citationsUsing Monoclonal Antibody Therapies for Multiple Sclerosis: A Review.Paul M. Elsbernd, Jonathan L. Carter
Biologics. 2021-06-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: